Literature DB >> 12215471

Noninvasive study of endothelial function in white coat hypertension.

Jorge Gómez-Cerezo1, Juan José Ríos Blanco, Inés Suárez García, Pilar Moreno Anaya, Pilar García Raya, Enrique Vázquez-Muñoz, Francisco Javier Barbado Hernández.   

Abstract

Several studies have demonstrated that endothelial dysfunction is present in patients with essential hypertension. However, the presence of endothelial dysfunction in patients with white coat hypertension has not been studied. We evaluated the variation in the diameter of the brachial artery produced by flow-mediated dilation after a mechanical stimulus in patients with recently diagnosed mild to moderate sustained essential hypertension compared with patients with white coat hypertension. A total of 29 patients fulfilled inclusion criteria; 15 healthy volunteers were also included. After 24-hour ambulatory blood pressure monitoring, 15 patients were classified with sustained essential hypertension; 14 patients with white coat hypertension. Vascular ultrasound scans were performed according to the method described by Celermajer et al, with modification for noninvasive determination of endothelial dysfunction. Basal brachial artery diameter did not differ significantly among the 3 groups. Changes in arterial diameter 60 seconds after cuff deflation were higher in the control group compared with both hypertensive groups, but no significant differences were found between the sustained essential hypertension group and the white coat hypertension group. Flow-mediated dilation was similar in white coat hypertensives and sustained essential hypertensives. The presence of endothelial dysfunction in subjects with white coat hypertension suggests that it should not be considered a harmless trait and that white coat hypertension has common features with sustained essential hypertension.

Entities:  

Mesh:

Year:  2002        PMID: 12215471     DOI: 10.1161/01.hyp.0000030198.48441.65

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Isolated office hypertension: association with target organ damage and cardiovascular risk indices.

Authors:  Nuri Kamel; Alptekin Gursoy; Osman Koseoglulari; Irem Dincer; Sevim Gullu
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

Review 2.  Closer look at white-coat hypertension.

Authors:  Nurver Turfaner Sipahioglu; Fikret Sipahioglu
Journal:  World J Methodol       Date:  2014-09-26

3.  White coat hypertension is more risky than prehypertension: important role of arterial wave reflections.

Authors:  Shih-Hsien Sung; Hao-Min Cheng; Kang-Ling Wang; Wen-Chung Yu; Shao-Yuan Chuang; Chih-Tai Ting; Edward G Lakatta; Frank C P Yin; Pesus Chou; Chen-Huan Chen
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

4.  Endothelial function in children with white-coat hypertension.

Authors:  Alexander Jurko; Tomas Jurko; Milan Minarik; Michal Mestanik; Andrea Mestanikova; Vladimir Micieta; Zuzana Visnovcova; Ingrid Tonhajzerova
Journal:  Heart Vessels       Date:  2018-01-29       Impact factor: 2.037

5.  Endothelial dysfunction in patients with exaggerated blood pressure response during treadmill test.

Authors:  Hyuk-Jae Chang; Jaehoon Chung; So-Yeon Choi; Myeong-Ho Yoon; Gyo-Seung Hwang; Joon-Han Shin; Seung-Jea Tahk; Byung-Il William Choi
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

Review 6.  Pediatric ambulatory blood pressure monitoring: indications and interpretations.

Authors:  Joseph T Flynn; Elaine M Urbina
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-07       Impact factor: 3.738

7.  Should white coat hypertension be treated?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-09       Impact factor: 3.738

8.  Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C.

Authors:  Emmanuel Androulakis; Nikolaos Papageorgiou; Eirini Lioudaki; Evaggelos Chatzistamatiou; Effimia Zacharia; Ioannis Kallikazaros; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-21       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.